定量与定性影像生物标志物与地图状萎缩生长速率之间的关联
这项前瞻性队列研究纳入科罗拉多大学AMD注册库中66例晚期非新生血管性年龄相关性黄斑变性伴地图状萎缩患者的121只眼,随访至2023年6月,评估影像生物标志物与地图状萎缩平方根转换生长速率的关联。平均随访3.7年间,平方根转换生长速率为0.268 mm/年,与年龄、女性、非渗出性视网膜下液、非渗出性视网膜下高反射物质、不完全性视网膜色素上皮和外层视网膜萎缩正相关,与体重指数、黄斑下脉络膜厚度、视网膜假性囊肿负相关。
要点
- 平均随访3.7年,地图状萎缩平均生长速率为1.430 mm²/年,平方根转换生长速率为0.268 mm/年。
- 校正人口学因素后,平方根转换生长速率与非渗出性视网膜下液(P < .001)、非渗出性视网膜下高反射物质(P = .037)、不完全性视网膜色素上皮和外层视网膜萎缩(P = .022)正相关。
- 平方根转换生长速率与黄斑下脉络膜厚度(P = .031)和视网膜假性囊肿(P = .030)负相关。
核心结论
- 选择性的患者人口学因素和基本临床相关影像生物标志物与地图状萎缩生长速率相关。
- 这些生物标志物可能在考虑用新型疗法治疗地图状萎缩患者时指导患者选择。
研究设计与样本
- 前瞻性队列研究,纳入2014年8月至2021年6月在科罗拉多大学AMD注册库登记的66例晚期非新生血管性年龄相关性黄斑变性伴地图状萎缩患者的121只眼,随访至2023年6月。
- 由两名分级者审阅入组时的多模态影像以评估影像生物标志物,测量入组至最终访视期间的地图状萎缩生长速率及平方根转换生长速率。
- 评估平方根转换生长速率与影像生物标志物、基线地图状萎缩病灶特征及患者人口学因素之间的关联。
主要发现
- 平均随访3.7年期间,平均地图状萎缩生长速率为1.430 mm²/年,平方根转换生长速率为0.268 mm/年。
- 平方根转换生长速率与患者年龄(P = .010)和女性(P = .035)正相关,与体重指数(P = .041)负相关。
- 校正上述人口学因素后,平方根转换生长速率与非渗出性视网膜下液(P < .001)、非渗出性视网膜下高反射物质(P = .037)、不完全性视网膜色素上皮和外层视网膜萎缩(P = .022)正相关。
- 校正后,平方根转换生长速率与黄斑下脉络膜厚度(P = .031)和视网膜假性囊肿(P = .030)负相关。
- 入组时较大的基线地图状萎缩面积与更快的地图状萎缩生长速率相关(P = .002),但与平方根转换生长速率无关。
临床怎么用
- 作者认为,这些生物标志物可能在考虑用新型疗法治疗地图状萎缩患者时指导患者选择。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Investigate associations between geographic atrophy (GA) growth rate and multimodal imaging biomarkers and patient demographics in patients with advanced non-neovascular age-related macular degeneration (nnAMD). DESIGN: Prospective cohort study. METHODS: One hundred twenty-one eyes of 66 patients with advanced nnAMD with GA enrolled in the University of Colorado AMD Registry from August 2014 to June 2021, with follow-up through June 2023. Multimodal images were reviewed by two graders for imaging biomarkers at enrollment. GA growth rate and square-root transformed (SQRT) GA growth rate were measured between enrollment and final visit. Associations between the outcome SQRT GA growth rate and imaging biomarkers, baseline GA lesions characteristics, and patient demographics were evaluated. RESULTS: Average GA growth rate was 1.430 mm2/year and SQRT GA growth rate was 0.268 mm/year over a mean of 3.7 years. SQRT GA growth rate was positively associated with patient age (P = .010) and female sex (0.035), and negatively associated with body mass index (0.041). After adjustment for these demographic factors, SQRT GA growth rate was positively associated with presence of non-exudative subretinal fluid (P < .001), non-exudative subretinal hyperreflective material (P = .037), and incomplete retinal pigment epithelium and outer retina atrophy (P = .022), and negatively associated with subfoveal choroidal thickness (P = .031) and presence of retinal pseudocysts (P = .030). Larger baseline GA size at enrollment was associated with faster GA growth rate (P = .002) but not SQRT GA growth rate. CONCLUSIONS: Select patient demographic factors and basic clinically-relevant imaging biomarkers were associated with GA growth rate. These biomarkers may guide patient selection when considering treating GA patients with novel therapeutics.
引用
- de Carlo Forest TE, Gill Z, Lisker-Cervantes A, et al. Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate. Am J Ophthalmol. 2024. PMID: 38552931. doi:10.1016/j.ajo.2024.03.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。